Global Advanced Therapy Medicinal Products (ATMP) Market Driven by Increased Focus on Gene Therapies and Expansion of Regenerative Medicine Applications

Insights into Market Size, Trends, Market Dynamics, Key Segments, and Emerging Players

Straits Research, a leading market research organization, announced the release of the report titled “Advanced Therapy Medicinal Products (ATMP) Market Size and Outlook —Forecasts till 2034”. The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

According to the report, the Advanced Therapy Medicinal Products (ATMP) market is valued at USD 49 billion in 2026, which is expected to grow to USD 170 billion by 2034. The projected CAGR for this period is 16.5%.

The Advanced Therapy Medicinal Products (ATMP) market is segmented based on therapy type, manufacturer, and region. Some of the insights provided in the report are highlighted below:

• The cell therapy segment is expected to register a CAGR of 22% during the forecast period.
• North America is expected to lead the market during the forecast period, owing to regulatory advantages and effective product launches by companies.
• Consumers worldwide are shifting toward regenerative medicine to reduce lifetime healthcare expenditure as well as minimize surgeries and long-term medication.
• Germany is expected to lead the Europe ATMP market due to early adoption of innovative therapies and a supportive reimbursement environment.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market.

Market Segments

1. By Therapy Type
   1. Cell Therapy
   2. Gene Therapy
   3. CAR-T Therapy
   4. Tissue Engineered Products
2. By Manufacturer
   1. Biopharmaceutical Companies
   2. Contract Development and Manufacturing Organizations (CDMOs)
   3. Digital Platform Providers
3. By Region
   1. North America
   2. Europe
   3. Asia Pacific
   4. Middle East and Africa
   5. Latin America